Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Tempe & Blue Catalyst fund owns 195,257 shares as of 12/31/07

Tempe & Blue Catalyst fund owns 195,257 shares as of 12/31/07

posted on Apr 03, 2008 03:08AM
Mutual FundShs HeldShs Chg%Chg$Chg*%Out%PortRpt Date
Catalyst Value Fund 191,257 45,000 30.8 49,839 0.0 8.9 12-31-07
Share
New Message
Please login to post a reply